Black Country and West Birmingham CCG is supporting the delivery of the NHS-Galleri trial. Galleri™ is a new blood test to detect cancer, often before symptoms appear.
The NHS-Galleri trial is a research trial to see how well the new Galleri™ test works in the NHS when used alongside standard cancer screening. The aim is to see whether the test can help to find cancers at an early stage when they are easier to treat. The trial is currently only recruiting participants who have received an invitation letter in the post. If you receive an invitation letter, read it carefully and if you want to participate, please follow the instructions for booking an appointment online or via the dedicated phoneline.
You may receive an invitation letter if:
- You are aged 50 to 77
- You have not been diagnosed or treated for cancer in the last 3 years
- You are registered with a GP in one of the areas where the trial is being run
The study is in partnership with NHS England and GRAIL and will be run by The Cancer Research UK & King’s College London Cancer Prevention Trials Unit, a team of cancer researchers and trial managers at King's College London (King’s).
GRAIL LLC. is a company in the United States that developed the Galleri test. They have also set up a branch in the UK, GRAIL Bio UK Ltd (GRAIL) who are the main funder and organiser of this trial.
For more information, visit nhs-galleri.org.